Treatment of Hashimoto's Thyroiditis
The recommended treatment for Hashimoto's thyroiditis is thyroid hormone replacement therapy with levothyroxine for patients with overt hypothyroidism or persistent TSH levels above 10 mIU/L, even in asymptomatic individuals. 1
Diagnostic Approach
- Diagnosis is based on elevated TSH levels, with or without low free T4, along with the presence of thyroid peroxidase antibodies 1, 2
- Both TSH and FT4 should be measured in symptomatic patients to differentiate between primary and central hypothyroidism 1
- Hashimoto's thyroiditis typically presents with a painless goiter and symptoms of hypothyroidism 2
Treatment Algorithm
For Overt Hypothyroidism (Elevated TSH with Low FT4)
- Initiate thyroid hormone replacement therapy with levothyroxine 1, 3
- Dosing considerations:
- Monitor TSH every 6-8 weeks while titrating hormone replacement to maintain TSH within reference range 1
- Once adequately treated, repeat testing every 6-12 months or with symptom changes 1
For Subclinical Hypothyroidism
- For TSH >10 mIU/L (persistent, measured 4 weeks apart): initiate levothyroxine even if asymptomatic 1
- For TSH between 4.5-10 mIU/L:
Special Considerations
- If both adrenal insufficiency and hypothyroidism are present, hydrocortisone should be given before thyroid hormone to avoid precipitating an adrenal crisis 4
- Development of low TSH on therapy suggests overtreatment or recovery of thyroid function; dose should be reduced or discontinued with close follow-up 1
- Liothyronine (T3) can be used in patients allergic to desiccated thyroid or thyroid extract derived from pork or beef 3
Treatment Outcomes
- Levothyroxine therapy can decrease thyroid volume in patients with Hashimoto's thyroiditis 5
- Treatment with levothyroxine leads to a decrease in thyroid peroxidase antibody levels in most patients, though antibodies become negative in only a minority of patients (16%) even after long-term treatment 6
- Prophylactic levothyroxine in euthyroid patients with Hashimoto's thyroiditis may reduce antibody levels and prevent thyroid volume increase, but this remains controversial 7
Monitoring
- After initiating therapy, monitor TSH every 6-8 weeks while titrating to goal 1
- Once stable, monitor TSH every 6-12 months or with symptom changes 1
- FT4 can help interpret abnormal TSH levels during therapy, as TSH may take longer to normalize 1
Pitfalls to Avoid
- Do not initiate thyroid hormone replacement in transient hypothyroidism during recovery phase of subacute thyroiditis 3
- Avoid overtreatment leading to iatrogenic hyperthyroidism, which can increase cardiovascular risk, especially in elderly patients 1
- Do not miss central hypothyroidism (low TSH with low FT4), which requires different evaluation and management 1